Interferon alpha-2b gene therapy (Medgenics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alpha-2b gene therapy (Medgenics)
Drug Alias NameInfradure Biopump干扰素α-2b基因治疗 - MedgenicsInterferon α-2b gene therapyInfradure
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transferenceInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAevi Genomic Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAevi Genomic Medicine
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A